Search research articles
Contact Us
Filters
Showing results (161-170 of 189) with videos related to
Page
of 19
Sort By:
The Journal of Pathology
|
October 22, 2008
TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival
S Perner, P L Wagner, A Soltermann, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
A stratified two-stage tumor molecular profiling algorithm to identify clinically actionable molecular alterations in pancreatic cancer
S Hussung, D Akhoundova, C Pistoni, et al.
The American Journal of Pathology
|
December 6, 2001
Tissue microarrays for rapid linking of molecular changes to clinical endpoints
J Torhorst, C Bucher, J Kononen, et al.
Journal of the National Cancer Institute
|
August 2, 2001
Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer
R Simon, A Nocito, T Hübscher, et al.
Journal of Clinical Pathology
|
June 29, 2004
Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma
M R Morris, E Maina, N V Morgan, et al.
Human Pathology
|
January 29, 1999
Polysomies but not Y chromosome losses have prognostic significance in pTa/pT1 urinary bladder cancer
M Neuhaus, U Wagner, U Schmid, et al.
Oncogene
|
January 12, 2010
Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas
R Sutter, O Shakhova, H Bhagat, et al.
Experimental Cell Research
|
April 25, 2000
Laminin alpha4 and integrin alpha6 are upregulated in regenerating dy/dy skeletal muscle: comparative expression of laminin and integrin isoforms in muscles regenerating after crush injury
L M Sorokin, M A Maley, H Moch, et al.
Oncogene
|
July 8, 2009
Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response
K Balamurugan, V-D Luu, M R Kaufmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 23, 2022
Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
A Krämer, T Bochtler, C Pauli, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 189) with videos related to
Sort By:
Page
of 19
The Journal of Pathology
|
October 22, 2008
TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival
S Perner, P L Wagner, A Soltermann, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
A stratified two-stage tumor molecular profiling algorithm to identify clinically actionable molecular alterations in pancreatic cancer
S Hussung, D Akhoundova, C Pistoni, et al.
The American Journal of Pathology
|
December 6, 2001
Tissue microarrays for rapid linking of molecular changes to clinical endpoints
J Torhorst, C Bucher, J Kononen, et al.
Journal of the National Cancer Institute
|
August 2, 2001
Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer
R Simon, A Nocito, T Hübscher, et al.
Journal of Clinical Pathology
|
June 29, 2004
Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma
M R Morris, E Maina, N V Morgan, et al.
Human Pathology
|
January 29, 1999
Polysomies but not Y chromosome losses have prognostic significance in pTa/pT1 urinary bladder cancer
M Neuhaus, U Wagner, U Schmid, et al.
Oncogene
|
January 12, 2010
Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas
R Sutter, O Shakhova, H Bhagat, et al.
Experimental Cell Research
|
April 25, 2000
Laminin alpha4 and integrin alpha6 are upregulated in regenerating dy/dy skeletal muscle: comparative expression of laminin and integrin isoforms in muscles regenerating after crush injury
L M Sorokin, M A Maley, H Moch, et al.
Oncogene
|
July 8, 2009
Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response
K Balamurugan, V-D Luu, M R Kaufmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 23, 2022
Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
A Krämer, T Bochtler, C Pauli, et al.
Page
of 19